Gross, A. M., Glassberg, B., Wolters, P. L., Dombi, E., Baldwin, A., Fisher, M. J., Kim, A., Bornhorst, M., Weiss, B. D., Blakeley, J. O., Whitcomb, P., Paul, S. M., Steinberg, S. M., Venzon, D. J., Martin, S., Carbonell, A., Heisey, K., Therrien, J., Kapustina, O., Dufek, A., Derdak, J., Smith, M. A., & Widemann, B. C. (2022). selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity. Neuro-oncology, 24(11), 1978–1988. http://access.bl.uk/ark:/81055/vdc_100169532710.0x000021